Back to ARIA Stock Lookup

ARIA Related Analyst Ratings

May 22, 2013 01:12 PM April Data on ARIAD's (ARIA) Iclusig Supports Bullish Thesis - RBC

Apr 12, 2013 07:17 AM Jefferies Maintains Bullish View on ARIAD Pharmaceuticals (ARIA)

Apr 1, 2013 08:24 AM Jefferies Likes Early Iclusig Sales Data for ARIAD Pharmaceuticals (ARIA)

Mar 28, 2013 07:26 AM Goldman Sachs Starts ARIAD Pharmaceuticals (ARIA) at Neutral

Feb 8, 2013 09:25 AM JMP Securities Starts ARIAD Pharmaceuticals (ARIA) at Market Outperform

Jan 3, 2013 11:18 AM UPDATE: Ariad Pharma (ARIA) Iclusig Launch Not Without Risks; Minority of Physicians View Warnings as Prohibitive

Dec 17, 2012 07:56 AM Jefferies Cuts PT on ARIAD Pharma (ARIA) Due to Iclusig Safety Issues, Maintains Buy

Nov 9, 2012 09:48 AM Guggenheim Starts ARIAD Pharmaceuticals (ARIA) at Buy

Oct 26, 2012 07:04 AM Citi Starts ARIAD Pharmaceuticals (ARIA) at Buy

Oct 23, 2012 06:44 AM Oppenheimer Downgrades ARIAD Pharmaceuticals (ARIA) to Perform

Oct 2, 2012 07:29 AM Jefferies Boosts Price Target on Ariad Pharmaceuticals (ARIA) as Drugs Show Promise

Oct 1, 2012 01:56 PM Brean Murray Carret & Co Increases Price Target on ARIAD (ARIA) to $35

Sep 10, 2012 06:51 AM BofA/Merrill Lynch Upgrades ARIAD Pharmaceuticals (ARIA) to Buy

Jul 30, 2012 07:58 AM William Blair Starts ARIAD Pharma (ARIA) at Outperform, $25 Target

Jun 6, 2012 08:58 AM Jefferies Maintains Bullish View on ARIAD (ARIA) Despite CRL

Jun 5, 2012 03:00 PM Barclays Reiterates an 'Overweight' on ARIAD Pharmaceuticals (ARIA); Ponatinib Demonstrated Acceptable Safety Profile

Apr 12, 2012 11:04 AM UPDATE - UBS Initiates Coverage on Ariad Pharma (ARIA) with a Buy; Ponatinib Can Be A Billion Dollar Drug

Apr 12, 2012 08:18 AM UBS Starts BMRN, RDEA, ARIA at Buy, ITMN, ACHN, HGSI, IRWD at Neutral

Mar 21, 2012 10:33 AM Jefferies Keeps Bullish Stance on ARIAD Pharmaceuticals (ARIA) Despite Negative FDA Panel Vote

Mar 15, 2012 07:48 AM Stifel Nicolaus Initiates/Restarts BIIB, AFFY, CELG, GILD, ACOR, ARQL, ARIA, EXEL, BSTC at Buy, AMGN, DNDN at Hold

Feb 29, 2012 09:59 AM Jefferies Raises Target on ARIAD Pharmaceuticals (ARIA) Following Q4 Results

Feb 14, 2012 08:11 AM RBC Capital Starts ARIAD Pharmaceuticals (ARIA) at Outperform

Jan 19, 2012 10:03 AM Maxim Group Starts ARIAD Pharmaceuticals (ARIA) at Buy

Oct 14, 2011 07:49 AM Rodman & Renshaw Starts ARIAD Pharmaceuticals (ARIA) at Market Outperform

Sep 7, 2011 05:54 PM BMO Starts Biotech Stocks: AMGN, HGSI, REGN, CELG at Outperform, AMLN, GILD, ARNA at Market Perform, BIIB at Underperform

Aug 25, 2011 01:30 PM Summer Street Starts ARIAD Pharmaceuticals (ARIA) at Buy

Aug 1, 2011 12:40 PM Monness, Crespi, Hardt Starts ARIAD Pharma (ARIA) at Buy, $22 Price Target

Jul 19, 2011 06:59 AM BofA/Merrill Lynch Starts ARIAD Pharmaceuticals (ARIA) at Neutral

Jul 15, 2011 12:12 PM Jefferies Raises Price Target on ARIAD Pharmaceuticals (ARIA) Following Meeting With Management

May 25, 2011 10:18 AM Brean Murray Carret & Co. Assumes Coverage on ARIAD Pharmaceuticals (ARIA) at Buy, $11 Price Target

Mar 30, 2011 12:53 PM Barclays Reiterates an 'Overweight' on ARIAD Pharmaceuticals (ARIA); Continued Execution on Ponatinib; Preclinical Solid Tumor Data at AACR

Mar 24, 2011 07:22 AM Williams Capital Starts ARIAD Pharmaceuticals (ARIA) at Outperform

Jan 19, 2011 01:16 PM Barclays reiterates an 'Overweight' on ARIAD Pharmaceuticals (ARIA); Why 3 Week PFS Increase May be Relevant

Jan 19, 2011 11:09 AM Canaccord Genuity Morning Coffee on ARIAD Pharma (ARIA): It Just Rolls Off Tongue

Jan 5, 2011 08:52 AM Ph3 Ridaforolimus Data for Sarcoma in 1Q11, Jefferies Raises Price Target on ARIAD Pharmaceuticals (ARIA)

Nov 10, 2010 12:04 PM Jefferies Lowers its EPS Estimates on ARIAD Pharmaceuticals (ARIA), Maintains Buy Rating and Price Target

Oct 4, 2010 01:52 PM Barclays on U.S. Biotechnology Weekly: Focus on 4Q10 Picks

May 5, 2010 03:09 PM Brean Murray Issuses Mid-Day Upgrade on ARIAD Pharma (ARIA); Stock Trades to Intraday Highs

Mar 18, 2010 09:06 AM Argus Downgrades ARIAD Pharmaceuticals (ARIA) to Hold

Nov 9, 2009 08:34 AM JP Morgan Upgrades Ariad Pharmaceuticals (ARIA) to Overweight

Oct 8, 2009 08:36 AM Brean Murray Initiates Coverage on Ariad Pharmaceuticals (ARIA) with a Hold; Strong Fundamentals, Cautious on Phase 3 Trial

Aug 17, 2009 08:51 AM Oppenheimer Initiates Coverage on ARIAD Pharmaceuticals (ARIA) with an Outperform

Jul 31, 2009 11:20 AM Merriman Curhan Downgrades ARIAD Pharma (ARIA) to Sell

Oct 21, 2008 10:51 AM Susquehanna Initiates Coverage on Ariad Pharmaceuticals (ARIA) with a Positive

Dec 14, 2007 07:31 AM Jefferies & Co Initiates Coverage on ARIAD Pharmaceuticals (ARIA) with a Buy

Dec 14, 2007 07:30 AM Jefferies & Co Initiates Coverage on Ariad Pharma (ARIA) with a Buy

Nov 28, 2007 07:49 AM J.P. Morgan Downgrades ARIAD Pharmaceuticals(ARIA) to Neutral

Feb 12, 2007 08:42 AM JP Morgan upgrades Ariad Pharma (ARIA) to Overweight

May 1, 2006 09:11 AM Banc of America downgrades Ariad Pharma (ARIA) to Neutral

Nov 11, 2005 08:30 AM Leerink Swann Initiates ARIA

Back to ARIA Stock Lookup